Raising awareness of the availability of safer and higher quality products
DublinAnd November 26, 2021 /PRNewswire/ – file “Global Implantable Drug Delivery Devices Market (2021-2026) by product, type, technology, application, end user, geography, competitive analysis and impact of Covid-19 with Ansoff Analysis Report added to ResearchAndMarkets.com an offer.
It is estimated that the global market for implantable drug delivery devices is 18.35 billion US dollars In 2021 it is expected to arrive 28.82 billion US dollars By 2026, at a compound annual growth rate of 9.45%.
The growth of the Implantable Pharmaceutical Devices Market is being driven by factors such as the increasing prevalence of chronic diseases, increasing awareness among people regarding Implantable Drug Delivery Devices, increasing demand for contraceptives, and intervention by the government and health organizations to ensure high patient safety. Standards. In addition, increasing awareness about the availability of higher quality and safer products, recent developments in drug management techniques, and increasingly rapid research and development to launch a new product and eliminate existing problems is expected to enhance growth potential over the coming years.
However, probabilities of implantable device failure, strict government regulations and policies, and high cost of devices are expected to constrain market growth in the forecast period.
The global Implantable Drug Delivery Devices market is further segmented on the basis of product, type, technology, application, end user, and geography.
By product, the market is categorized into contraceptive implants, spinal implants, brachytherapy implants, drug lubricant stents, bioabsorbable stents, intraocular implants, infusion pumps, and others. Among all, the pharmaceutical-enriched stents segment is estimated to hold the highest market share during the forecast period.
By type, the market is categorized as biodegradable and non-biodegradable. Among the two, the non-degradable segment is estimated to hold the highest market share during the forecast period.
By technology, the market is categorized as diffusion, osmotic and magnetic. Among all, the diffusion segment is estimated to hold the highest market share during the forecast period.
By application, the market is categorized as ophthalmology, cardiology, obstetrics and gynecology, diabetes, oncology, and autoimmune diseases, among others. Among all, the cardiovascular segment is expected to hold the highest market share during the forecast period.
By the end user, the market is categorized as hospitals, ambulatory surgery centers, and others. Among all, the hospital segment is estimated to hold the highest market share during the forecast period.
according to geography, North Amarica It is expected to lead the market.
1. The Food and Drug Administration (FDA) accepts Roche’s Port Delivery System with ranibizumab (PDS) for the treatment of neovascularization or age-related macular degeneration (nAMD). If approved, PDS would be the first eye implant with continuous drug delivery that provides people living with nAMD with an alternative to frequent eye injections. June 24, 2021.
2. Siemens Healthineers acquires Varian, cementing its position as a comprehensive healthcare partner – April 15, 202
Complete analysis of the market, including the parent industry
Important market dynamics and trends
Historical, current and projected market size based on value and volume
Market shares and strategies of key players
Recommendations for companies to strengthen their foothold in the market
Main topics covered:
1 Description of the report
2 Research Methodology
3 Executive Summary
4 market influencers
4.1.1 Increasing prevalence of chronic diseases
4.1.2 Increasing demand for minimally invasive drug delivery devices
4.2.1 Strict government regulations
4.2.2 High machine cost
4.3.1 Collaboration activities between key players
4.4.1 Product recall
5 Market Analysis
5.1 Regulatory scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis
6 Global Medical Implant Drugs Market, by Product
6.2 Contraceptive implants
6.3 Spine Implant
6.4 Brachytherapy seeds
6.5 Medication cracking struts
6.6 Bioabsorbable stents
6.7 Implants inside the eye
6.8 Infusion pumps
7 Global Market for Implantable Drugs Market by Type
8 Global Implantable Drugs Market Market, By Technology
9 Global Implantable Drugs Market, by Application
9.3 Heart disease
9.4 Obstetrics and Gynecology
9.7 Autoimmune diseases 9.8 Other diseases
10 Other Global Implantable Drug Delivery Devices Market, By End User
10.3 Mobile surgery centers
11 Global Implantable Drugs Market, By Geography
12 competitive scenes
12.1 Competitive Quarter
12.2 Market share analysis
12.3 Strategic Initiatives
12.3.1 PM& A & Investments
12.3.2 Partnerships and Collaboration
12.3.3 Product Developments and Improvements
13 Company Profiles
13.1 Abbott Laboratories
13.2 Abbvie Corporation
13.3 Allergan Corporation
13.4 Alcon . Company
13.5 Bayer AG
13.6 Bausch & Lomb Incorporated
13.7 Biotronik, Inc.
13.8 Boston Scientific Institute
13.9 DSM Biomedicine
13.10 Delpor Inc.
13.11 Medtronic plc.
13.12 Merck & co., Inc.
13.13 Freudenberg Medical, LLC
13.16 Siemens Healtheners
13.17 Theradaptive, Inc.
13.18 Intersection of the ear, nose and throat
13.19 Nanomedical Systems, Inc.
13.20 Intarcia Therapeutics
13.21 Teleflex Incorporated
13.22 Terumo . Company
13.23 Alimera Sciences
13.24 Pharmaceutical drugs
13.25 Delpor . Company
13.26 3M a company
For more information about this report visit https://www.researchandmarkets.com/r/xlibzk
Research and Markets
Laura Wood, director, mentor
For EST office hours, call +1-917-300-0470
For the US/Canada, call toll free +1-800-526-8630
For GMT office hours, call +353-1-416-8900
US Fax: 607-646-1904
Fax (outside the US): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/global-18-35-bn-implantable-drug-delivery-device-market-to-2026-rising-awareness-on-the-availability-of-high- Quality and safety products -301432358.html
SOURCE Research & Markets